Most research reveals 30 to 40 percent of women in the United States say they have sexual issues. A recent study examined how many women consider their sex issues to be a problem. With host Dr. Lauren Streicher, Dr. Jan Shifren, an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, looks at the findings of her research. The two review the impetus for the study, questions that were asked from 30,000 participants, and what has been gleaned from the results. The two also touch on whether testosterone and Viagra should be prescribed to help women who are distressed by their sexual issues.
How to Help Women with Sexual Issues
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Most research reveals 30 to 40 percent of women in the United States say they have sexual issues. A recent study examined how many women consider their sex issues to be a problem. With host Dr. Lauren Streicher, Dr. Jan Shifren, an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, looks at the findings of her research. The two review the impetus for the study, questions that were asked from 30,000 participants, and what has been gleaned from the results. The two also touch on whether testosterone and Viagra should be prescribed to help women who are distressed by their sexual issues.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Clinician's Roundtable
AI and Hair Loss: Measuring Progress with Data-Driven Insights
<p>AI and Hair Loss: Measuring Progress with Data-Driven Insights</p>
Clinician's Roundtable
Challenges in AI-Driven Dermatology: Understanding Current Limitations
<p>Challenges in AI-Driven Dermatology: Understanding Current Limitations</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?